Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity.
about
Drugs for preventing red blood cell dehydration in people with sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseasePrecipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional considerationHypoxic adaptation during development: relation to pattern of neurological presentation and cognitive disability.Acute chest syndrome: sickle cell disease.High protein diet attenuates histopathologic organ damage and vascular leakage in transgenic murine model of sickle cell anemiaProtective effect of arginine on oxidative stress in transgenic sickle mouse models.Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.The Role of Nutrition in Sickle Cell Disease.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Body composition and grip strength are improved in transgenic sickle mice fed a high-protein dietA transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress.Continuous exposure to L-arginine induces oxidative stress and physiological tolerance in cultured human endothelial cells.Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trialCardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.Strain-specific variations in cation content and transport in mouse erythrocytes.Endothelial Nitric Oxide Synthase (-786T>C) and Endothelin-1 (5665G>T) Gene Polymorphisms as Vascular Dysfunction Risk Factors in Sickle Cell Anemia.A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodesArginine metabolism and nutrition in growth, health and diseaseEndothelin-1 receptor antagonists regulate cell surface-associated protein disulfide isomerase in sickle cell disease.Novel small molecule therapeutics for sickle cell disease: nitric oxide, carbon monoxide, nitrite, and apolipoprotein A-I.Malnutrition in Sickle Cell Anemia: Implications for Infection, Growth, and Maturation.Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapyInvestigational drugs in sickle cell anemia.Determinants of erythrocyte hydration.Novel therapies targeting the endothelium in sickle cell disease.Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine.In vitro evidence of the inhibitory capacity of chloroquine on arginase activity in sickle erythrocytes.The proverbial chicken or the egg? Dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology.Brain neurochemical and hemodynamic findings in the NY1DD mouse model of mild sickle cell disease.Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?Arginine supplementation improves rotorod performance in sickle transgenic mice.Do we kNOw how HSP90 and eNOS mediate lung injury in sickle cell disease?Nitric oxide pathology and therapeutics in sickle cell disease.
P2860
Q24186046-E6A24311-B361-4D73-A21E-2613F8DF878EQ24202032-353E4DE2-E8EB-45B8-9782-DADC6983936CQ24240777-EA156C57-A3A3-4F5F-A475-87862C09A657Q26742061-F35A7ADE-D61B-4E96-B474-F7F2299D25DBQ31043815-CD3EA6A9-54DC-4559-BBCB-34B06B04B3DCQ34187526-1CC3F0B8-F000-4F88-8B92-1BD43B3FEF45Q34543856-2C6B2264-980C-419A-9A74-7F1754D284E0Q34589136-45304CBE-3214-496D-8303-786D83D8AA65Q34775883-E5BDFE7E-CC41-4F3F-A0D3-E30250015F81Q34891505-8A213BC9-2C0D-475D-8DF6-E5D52616481BQ34898802-4BCF2508-82DD-42C3-BA93-007A2B9159B3Q35668179-A90763F0-0238-416F-A4BF-6046F5104347Q35848216-C9C9E521-CCD6-48E6-89AE-1CCA21FBB55FQ35874747-3564C9EE-B45B-4B74-83F6-822C778D1BF8Q36112390-17ABBDD7-A582-46E3-8C58-022891B60AF1Q36419650-4237AA11-5831-4B08-814A-FF3FA38236DEQ36850738-7D08AF39-A232-4029-955C-AC5CA65B3588Q37138208-829AED90-938C-4B1B-AF24-B8D6917B94E7Q37144863-77513E90-8A24-4FEF-A758-4A197205F73EQ37179500-CB038A6E-1B75-4DBE-94AF-533871A8C95BQ37245989-678B2399-07C6-413D-8CC0-FC8CC3E0C2F3Q37346719-C3EFB111-686B-47F7-932B-F36FBCAB50CEQ37359292-203917A6-399C-4258-83B6-17393CA6BC3EQ37415993-7E893546-2E56-4234-835B-EC6A8F0E9F0CQ37603352-827849D5-6272-439A-82D7-7C3EF49B4367Q37698164-B699102A-3FA2-4C0B-BE6B-DEC9D44E6835Q37930655-FA176BFB-7C0B-4648-8132-5838577E5323Q39226887-C3C8C639-3175-43D1-8CEA-A160AFFE0838Q41942150-8674B483-DC6B-4097-8F74-EFA6294AFA00Q42349186-A7935C57-A02A-4F9D-9BBD-8B6D4F44352BQ42505511-5E4E2B6C-4440-48BD-829B-1CE9C672C7B5Q44355177-AB0F2890-40A0-4F4C-94C1-105543DFCB18Q45204114-9E808190-6322-4984-A2B3-3D56AEAB39D9Q47992762-B1E4A5E8-411F-403B-9618-77082E914CCBQ52722001-38275B22-0A43-4E3B-8399-6C7601565A0A
P2860
Arginine supplementation of sickle transgenic mice reduces red cell density and Gardos channel activity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Arginine supplementation of si ...... y and Gardos channel activity.
@en
Arginine supplementation of si ...... y and Gardos channel activity.
@nl
type
label
Arginine supplementation of si ...... y and Gardos channel activity.
@en
Arginine supplementation of si ...... y and Gardos channel activity.
@nl
prefLabel
Arginine supplementation of si ...... y and Gardos channel activity.
@en
Arginine supplementation of si ...... y and Gardos channel activity.
@nl
P2093
P356
P1433
P1476
Arginine supplementation of si ...... y and Gardos channel activity.
@en
P2093
José R Romero
Mary E Fabry
Ronald L Nagel
Sandra M Suzuka
P304
P356
10.1182/BLOOD.V99.4.1103
P407
P577
2002-02-01T00:00:00Z